Viiv Health Care Stock Price

Listing Websites about Viiv Health Care Stock Price

Filter Type:

GSK/Pfizer-Backed ViiV Healthcare's HIV Treatment At Par With …

(Just Now) WEBPrice Action: GSK stock is down 1.54% at $35.19, and PFE shares are down 0.31% at $42.25 during the premarket session on the last check Thursday. Don't …

https://finance.yahoo.com/news/gsk-pfizer-backed-viiv-healthcares-154336744.html

Category:  Health Show Health

ViiV Healthcare announces U.S. FDA approval of Dovato …

(7 days ago) WEBDURHAM, N.C., April 08, 2024--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the U.S. …

https://finance.yahoo.com/news/viiv-healthcare-announces-u-fda-122300021.html

Category:  Health Show Health

ViiV Healthcare : FDA Approves Apretude, Long-acting - Nasdaq

(2 days ago) WEB(RTTNews) - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK, GSK.L), with Pfizer Inc. (PFE) and Shionogi …

https://www.nasdaq.com/articles/viiv-healthcare-%3A-fda-approves-apretude-long-acting-injectable-option-for-hiv-prevention

Category:  Health Show Health

ViiV Healthcare's Cabenuva Shows Superiority In HIV Viral Load

(6 days ago) WEB(RTTNews) - ViiV Healthcare announced results from an interim analysis of the LATITUDE phase III trial, indicating their long-acting injectable antiretroviral …

https://markets.businessinsider.com/news/stocks/viiv-healthcare-s-cabenuva-shows-superiority-in-hiv-viral-load-suppression-interim-trial-analysis-1033086273

Category:  Health Show Health

GSK unit ViiV raises outlook on long-term HIV therapies

(Just Now) WEBViiV Healthcare, majority owned by GSK, raises growth outlook on strength of long-acting HIV treatments, with sales projected to grow 6-8% through 2026. Read …

https://seekingalpha.com/news/4016632-gsk-unit-viiv-raises-outlook-long-term-hiv-therapies

Category:  Health Show Health

ViiV Healthcare - Markets Insider

(5 days ago) WEB(RTTNews) - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK, GSK.L), with Pfizer Inc. (PFE) and Shio

https://markets.businessinsider.com/news/stocks/viiv-healthcare-fda-approves-apretude-long-acting-injectable-option-for-hiv-prevention-1031058136

Category:  Health Show Health

ViiV Healthcare : FDA Approves Label Update For Long-acting HIV

(9 days ago) WEBMar. 24, 2022, 10:29 PM. (RTTNews) - The US Food and Drug Administration approved a label update for long-acting HIV treatment Cabenuva (cabotegravir, rilpivirine), allowing …

https://markets.businessinsider.com/news/stocks/viiv-healthcare-fda-approves-label-update-for-long-acting-hiv-treatment-cabenuva-1031306584

Category:  Food Show Health

GlaxoSmithKline's ViiV Healthcare Receives FDA Approval For

(4 days ago) WEB(RTTNews) - ViiV Healthcare, the global specialist HIV company majority-owned by GlaxoSmithKline plc (GSK, GSK.L), with Pfizer and Shionogi Limitedas …

https://www.nasdaq.com/articles/glaxosmithklines-viiv-healthcare-receives-fda-approval-for-hiv-treatment

Category:  Health Show Health

ViiV Healthcare announces FDA approval of two-month dosing of …

(6 days ago) WEBViiV Healthcare, majority-owned by GlaxoSmithKline (GSK), announced that the FDA approved an every-two-month dosing regimen of the company’s HIV therapy …

https://seekingalpha.com/news/3794065-viiv-healthcare-announces-fda-approval-of-two-month-dosing-of-cabenuva-for-hiv

Category:  Health Show Health

ViiV Healthcare announces interim data at CROI indicating …

(8 days ago) WEBViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced data from a …

https://www.marketscreener.com/quote/stock/PFIZER-INC-23365019/news/ViiV-Healthcare-announces-interim-data-at-CROI-indicating-superior-efficacy-of-long-acting-injectabl-46111440/

Category:  Health Show Health

ViiV Healthcare Co - Company Profile and News - Bloomberg …

(3 days ago) WEBCompany profile page for ViiV Healthcare Co including stock price, company news, executives, board members, and contact information. Viiv Healthcare Company was …

https://www.bloomberg.com/profile/company/0934153D:US

Category:  Health Show Health

GSK lifts growth target for HIV business on demand for long …

(8 days ago) WEBSept 28 - GSK (GSK.L) on Thursday lifted its medium-term growth forecast for its HIV drugs business ViiV, encouraged by strong sales of long-acting injections that aim to replace …

https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-lifts-growth-ambitions-hiv-business-long-acting-drug-2023-09-28/

Category:  Health Show Health

ViiV Healthcare Company Profile 2024: Valuation, Funding

(8 days ago) WEBThe current revenue for ViiV Healthcare is 000000. Who are ViiV Healthcare’s investors? Shionogi & Co. , GSK , and Pfizer (Pharmaceuticals) have invested in ViiV Healthcare.

https://pitchbook.com/profiles/company/104459-32

Category:  Health Show Health

ViiV Healthcare - Wikipedia

(5 days ago) WEBViiV Healthcare (/ ˈ v iː v / VEEV) is a British multinational pharmaceutical company specializing in the research and development of medicines to treat and prevent …

https://en.wikipedia.org/wiki/ViiV_Healthcare

Category:  Medicine Show Health

The Hidden Gem Of GlaxoSmithKline's Balance Sheet - Seeking …

(1 days ago) WEBViiV healthcare is invisible on GSK's balance sheet with a negative net position of contingent consideration outweighing intangible assets by £0.7 BN ($1.1 BN). …

https://seekingalpha.com/article/3452586-viiv-healthcare-hidden-gem-of-glaxosmithklines-balance-sheet

Category:  Health Show Health

ViiV Healthcare Ltd Reuters

(2 days ago) WEBFebruary 22, 2023. 1 to 3 of 3. The latest international ViiV Healthcare Ltd news and views from Reuters - one of the world's largest news agencies.

https://www.reuters.com/company/viiv-healthcare-ltd/

Category:  Health Show Health

GSK: ViiV Healthcare Gets FDA Approval For HIV Treatment …

(5 days ago) WEB(RTTNews) - GlaxoSmithKline plc (GSK, GSK.L) said Friday that its majority-owned specialist HIV company ViiV Healthcare has received approval from the US Food …

https://markets.businessinsider.com/news/stocks/gsk-viiv-healthcare-gets-fda-approval-for-hiv-treatment-cabenuva-quick-facts-1029993099

Category:  Food Show Health

ViiV Healthcare SPRL - Company Profile and News

(3 days ago) WEBCompany profile page for ViiV Healthcare SPRL including stock price, company news, executives, board members, and contact information

https://www.bloomberg.com/profile/company/0651494D:BB

Category:  Health Show Health

Filter Type: